Log in

Trans-anal surgery with the taTME technique for rectal gastrointestinal stromal tumors: a retrospective study

  • Research
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

Rectal gastrointestinal stromal tumors (GISTs) surgery is often challenging owing to the anatomical constraints of the narrow pelvis and tumor hugeness. Despite the increasing number of patients undergoing trans-anal total mesorectal excision (taTME) globally, the feasibility of trans-anal surgery with the taTME technique for rectal GISTs remains unclear. We aimed to evaluate the feasibility of trans-anal surgery with the taTME technique for rectal GISTs.

Methods

Using a prospectively collected database, we retrospectively analyzed the clinical findings, surgical outcomes, pathological outcomes, urinary and anal functions, and prognoses of patients who underwent trans-anal surgery with the taTME technique for primary rectal GISTs at the National Cancer Center Hospital East from September 2014 to March 2020.

Results

Twenty-one patients with primary rectal GISTs were included in this study. The median distance from the anal verge to the lower edge of the tumor was 40 mm (range, 15–60 mm), and the median tumor size was 59 mm (range, 11–175 mm). Moreover, seven and 14 patients underwent one-team and two-team surgeries, respectively, with curative intent. Nineteen patients (90.5%) underwent anus-preserving surgery, and the urinary tracts were preserved in all cases. Two-team surgery showed a significantly lower blood loss volume and shorter operation time than one-team surgery (58 vs. 222 mL, P = 0.017; 184 vs 356 min, P = 0.041, respectively). The pathological negative-margin resection rate was 100%. During the follow-up period, no patient developed local GIST recurrence and one (4.8%) developed distant metastasis.

Conclusion

Trans-anal surgery with the taTME technique is feasible for rectal GISTs, and two-team surgery may be more advantageous than one-team surgery in terms of operation time and blood loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data sharing and accessibility

The datasets generated and analyzed during the present study are available from the corresponding author upon reasonable request.

References

  1. Tran T, Davila JA, El-Serag HB (2005) The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 100:162–168. https://doi.org/10.1111/j.1572-0241.2005.40709.x

    Article  PubMed  Google Scholar 

  2. Wilkinson MJ, Fitzgerald JEF, Strauss DC, Hayes AJ, Thomas JM, Messiou C et al (2015) Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib. Br J Surg 102:965–971. https://doi.org/10.1002/bjs.9818

    Article  CAS  PubMed  Google Scholar 

  3. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58. https://doi.org/10.1097/00000658-200001000-00008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Duffaud F, Blay JY (2003) Gastrointestinal stromal tumors: biology and treatment. Oncology 65:187–197. https://doi.org/10.1159/000074470

    Article  PubMed  Google Scholar 

  5. Kumar M, Goel MM, Singh D (2013) Rare case of gastrointestinal stromal tumor of the anal canal. J Cancer Res Ther 9:736–738. https://doi.org/10.4103/0973-1482.126476

    Article  PubMed  Google Scholar 

  6. Singhal S, Singhal A, Tugnait R, Varghese V, Tiwari B, Arora PK et al (2013) Anorectal gastrointestinal stromal tumor: a case report and literature review. Case Rep Gastrointest Med 2013:934875. https://doi.org/10.1155/2013/934875

    Article  PubMed  PubMed Central  Google Scholar 

  7. Manimaran D, Khan DM, Bharathi K, Raman TR, Anuradha S (2015) Gastrointestinal stromal tumor of the anal canal. Natl J Lab Med 4:38–39

    Google Scholar 

  8. Nagasaki T, Fukunaga Y, Akiyoshi T, Konishi T, Fujimoto Y, Nagayama S et al (2017) Laparoscopic total pelvic exenteration after neoadjuvant imatinib therapy for gastrointestinal stromal tumor of the rectum: a case report. Int Surg 102:205–209. https://doi.org/10.9738/INTSURG-D-15-00041.1

    Article  Google Scholar 

  9. Kyo K, Azuma M, Okamoto K, Nishiyama M, Shimamura T, Maema A et al (2016) Neoadjuvant imatinib treatment and laparoscopic anus-preserving surgery for a large gastrointestinal stromal tumor of the rectum. World J Surg Oncol 14:68. https://doi.org/10.1186/s12957-016-0837-1

    Article  PubMed  PubMed Central  Google Scholar 

  10. Fujimoto Y, Akiyoshi T, Konishi T, Nagayama S, Fukunaga Y, Ueno M (2014) Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum. Int J Colorectal Dis 29:111–116. https://doi.org/10.1007/s00384-013-1769-7

    Article  PubMed  Google Scholar 

  11. Nakamura T, Ihara A, Mitomi H, Kokuba Y, Sato T, Ozawa H et al (2007) Gastrointestinal stromal tumor of the rectum resected by laparoscopic surgery: report of a case. Surg Today 37:1004–1008. https://doi.org/10.1007/s00595-007-3509-5

    Article  PubMed  Google Scholar 

  12. Nagano S, Miyoshi N, Takahashi T, Itakura H, Fu**o S, Ogino T et al (2020) Preoperative imatinib and laparoscopic intersphincteric resection for large rectal gastrointestinal stromal tumor: a case report. Int J Surg Case Rep 71:235–239. https://doi.org/10.1016/j.ijscr.2020.05.031

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sylla P, Rattner DW, Delgado S, Lacy AM (2010) NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 24:1205–1210. https://doi.org/10.1007/s00464-010-0965-6

    Article  PubMed  Google Scholar 

  14. van Oostendorp SE, Koedam TWA, Sietses C, Bonjer HJ, Tuynman JB (2018) Transanal total mesorectal excision compared to laparoscopic TME for mid and low rectal cancer – current evidence. Ann Laparosc Endosc Surg 3:41. https://doi.org/10.21037/ales.2018.04.02

  15. Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B et al (2015) Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg 221:415–423. https://doi.org/10.1016/j.jamcollsurg.2015.03.046

    Article  PubMed  Google Scholar 

  16. Shiraishi T, Ito M, Sasaki T, Nishizawa Y, Tsukada Y, Ikeda K (2021) Association between urinary function and resected pattern of the autonomic nerve system after transanal total mesorectal excision for rectal cancer. Colorectal Dis 23:405–414. https://doi.org/10.1111/codi.15416

    Article  CAS  PubMed  Google Scholar 

  17. Enomoto H, Ito M, Sasaki T, Nishizawa Y, Tsukada Y, Ikeda K, Hasegawa H (2022) Anastomosis-related complications following stapled anastomosis with reinforced sutures in transanal total mesorectal excision for low rectal cancer: A retrospective single-center study. Dis Colon Rectum 65:2021. https://doi.org/10.1097/DCR.0000000000002016

    Article  Google Scholar 

  18. Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J et al (2019) Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision: results from the international TaTME registry. Ann Surg 269:700–711. https://doi.org/10.1097/SLA.0000000000002653

    Article  PubMed  Google Scholar 

  19. Roodbeen SX, De Lacy FB, van Dieren S, Penna M, Ris F, Moran B et al (2019) Predictive factors and risk model for positive circumferential resection margin rate after transanal total mesorectal excision in 2653 patients with rectal cancer. Ann Surg 270:884–891. https://doi.org/10.1097/SLA.0000000000003516

    Article  PubMed  Google Scholar 

  20. Hasegawa S, Okada T, Hida K, Kawada K, Sakai Y (2016) Transperineal minimally invasive approach for extralevator abdominoperineal excision. Surg Endosc 30:4620–4621. https://doi.org/10.1007/s00464-015-4736-2

    Article  PubMed  Google Scholar 

  21. Nagakari K, Matoba S, Toda S, Maeda Y, Ueno M, Kuroyanagi H (2021) Hybrid resection of massive rectal gastrointestinal stromal tumor using laparoscopic and transanal approaches. Asian J Endosc Surg 14:102–105. https://doi.org/10.1111/ases.12824

    Article  PubMed  Google Scholar 

  22. Wachter N, Wörns MA, Dos Santos DP, Lang H, Huber T, Kneist W (2016) Transanal minimally invasive surgery (TAMIS) approach for large juxta-anal gastrointestinal stromal tumour. J Minim Access Surg 12:289–291. https://doi.org/10.4103/0972-9941.181306

    Article  PubMed  PubMed Central  Google Scholar 

  23. Carrillo R, Candia A, Rodriguez-Peralto JL, Caz V (1997) Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol 28:160–165. https://doi.org/10.1016/s0046-8177(97)90100-3

    Article  CAS  PubMed  Google Scholar 

  24. Arroyave MC, DeLacy FB, Lacy AM (2017) Transanal total mesorectal excision (TaTME) for rectal cancer: step by step description of the surgical technique for a two-teams approach. Eur J Surg Oncol 43:502–505. https://doi.org/10.1016/j.ejso.2016.10.024

    Article  CAS  PubMed  Google Scholar 

  25. Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L et al (2016) Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer 16:380. https://doi.org/10.1186/s12885-016-2428-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Chen CC, Lai YL, Jiang JK, Chu CH, Huang IP, Chen WS et al (2016) Transanal total mesorectal excision versus laparoscopic surgery for rectal cancer receiving neoadjuvant chemoradiation: a matched case-control study. Ann Surg Oncol 23:1169–1176. https://doi.org/10.1245/s10434-015-4997-y

    Article  PubMed  Google Scholar 

  27. Koedam TWA, Veltcamp Helbach MV, Van de Ven PM, Kruyt PM, van Heek NT, Bonjer HJ et al (2018) Transanal total mesorectal excision for rectal cancer: evaluation of the learning curve. Tech Coloproctol 22:279–287. https://doi.org/10.1007/s10151-018-1771-8

    Article  CAS  PubMed  Google Scholar 

  28. Imaizumi K, Tsukada Y, Komai Y, Nomura S, Ikeda K, Nishizawa Y et al (2019) Prediction of urinary retention after surgery for rectal cancer using voiding efficiency in the 24 h following Foley catheter removal. Int J Colorectal Dis 34:1431–1443. https://doi.org/10.1007/s00384-019-03333-y

    Article  PubMed  Google Scholar 

  29. Jorge JMN, Wexner SD (1993) Etiology and management of fecal incontinence. Dis Colon Rectum 36:77–97. https://doi.org/10.1007/BF02050307

    Article  CAS  PubMed  Google Scholar 

  30. Chaudhry UI, DeMatteo RP (2011) Advances in the surgical management of gastrointestinal stromal tumor. Adv Surg 45:197–209. https://doi.org/10.1016/j.yasu.2011.03.018

    Article  PubMed  PubMed Central  Google Scholar 

  31. ESMO/European Sarcoma Network Working Group (2014) Gastrointestinal stromal tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):iii21–iii26. https://doi.org/10.1093/annonc/mdu255

    Article  Google Scholar 

  32. Liu H, Yan Z, Liao G, Yin H (2014) Treatment strategy of rectal gastrointestinal stromal tumor (GIST). J Surg Oncol 109:708–713. https://doi.org/10.1002/jso.23562

    Article  PubMed  Google Scholar 

  33. Guo W, Yang Z, Wei Y, Qin X, Li C, Huang R et al (2020) Radical excision versus local resection for primary rectal gastrointestinal stromal tumors. Cohort Study Int J Surg 77:190–197. https://doi.org/10.1016/j.ijsu.2020.03.068

    Article  PubMed  Google Scholar 

  34. Jakob J, Mussi C, Ronellenfitsch U, Wardelmann E, Negri T, Gronchi A, Hohenberger P (2013) Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib. Ann Surg Oncol 20:586–592. https://doi.org/10.1245/s10434-012-2647-1

    Article  PubMed  Google Scholar 

  35. Pai VD, Demenezes JL, Patil PS, Saklani AP (2016) Multimodality therapy of rectal gastrointestinal stromal tumors in the era of imatinib-an Indian series. J Gastrointest Oncol 7:262–268. https://doi.org/10.3978/j.issn.2078-6891.2015.088

    Article  PubMed  PubMed Central  Google Scholar 

  36. Agaimy A, Vassos N, Märkl B, Meidenbauer N, Köhler J, Spatz J et al (2013) Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach. Int J Colorectal Dis 28:1057–1064. https://doi.org/10.1007/s00384-013-1655-3

    Article  PubMed  Google Scholar 

  37. IJzerman NS, Mohammadi M, Tzanis D, Gelderblom H, Fiore M, Fumagalli E et al (2020) Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour (GIST) in a large European cohort. Eur J Surg Oncol 46:1124–1130. https://doi.org/10.1016/j.ejso.2020.02.033

    Article  PubMed  Google Scholar 

  38. Shu P, Sun XF, Fang Y, Gao XD, Hou YY, Shen KT et al (2020) Clinical outcomes of different therapeutic modalities for rectal gastrointestinal stromal tumor: summary of 14-year clinical experience in a single center. Int J Surg 77:1–7. https://doi.org/10.1016/j.ijsu.2020.03.007

    Article  CAS  PubMed  Google Scholar 

  39. Eisenberg BL, Judson I (2004) Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol 11:465–475. https://doi.org/10.1245/ASO.2004.09.011

    Article  PubMed  Google Scholar 

  40. Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J et al (2017) Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg 266:111–117. https://doi.org/10.1097/SLA.0000000000001948

    Article  PubMed  Google Scholar 

  41. Qu H, Xu Z, Ren Y, Gong Z, Ju RH, Zhang F et al (2022) Recent advancements in the treatment of rectal gastrointestinal stromal tumor: in era of imatinib. Cancer Manag Res 14:1141–1152. https://doi.org/10.2147/CMAR.S352860

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC et al (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14:210–218. https://doi.org/10.1016/S1470-2045(13)70016-0

    Article  PubMed  Google Scholar 

  43. Burke JP, Martin-Perez B, Khan A, Nassif G, de Beche-Adams T, Larach SW et al (2016) Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients. Colorectal Dis 18:570–577. https://doi.org/10.1111/codi.13263

    Article  CAS  PubMed  Google Scholar 

  44. Aubert M, Mege D, Panis Y (2020) Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis. Surg Endosc 34:3908–3919. https://doi.org/10.1007/s00464-019-07160-8

    Article  PubMed  Google Scholar 

  45. Chen CC, Lai YL, Jiang JK, Chu CH, Huang IP, Chen WS et al (2015) The evolving practice of hybrid natural orifice transluminal endoscopic surgery (NOTES) for rectal cancer. Surg Endosc 29:119–126. https://doi.org/10.1007/s00464-014-3659-7

    Article  CAS  PubMed  Google Scholar 

  46. Fernández-Hevia M, Delgado S, Castells A, Tasende M, Momblan D, Díaz del Gobbo GD et al (2015) Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery. Ann Surg 261:221–227. https://doi.org/10.1097/SLA.0000000000000865

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the staff of the National Cancer Center Hospital East, Kashiwa, Japan.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Takahiro Shigaki, Yuichiro Tsukada, and Masaaki Ito. The first draft of the manuscript was written by Takahiro Shigaki, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Masaaki Ito.

Ethics declarations

Ethics approval and consent to participate

This study was conducted in accordance with the provisions of the Declaration of Helsinki and approved by the institutional ethics review board of the National Cancer Center Hospital East, Japan (approval no. 2018–100). We applied opt-out method to obtain consent on this study using the document that was approved by the institutional review board.

Consent to publish

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shigaki, T., Tsukada, Y., Teramura, K. et al. Trans-anal surgery with the taTME technique for rectal gastrointestinal stromal tumors: a retrospective study. Int J Colorectal Dis 37, 1975–1982 (2022). https://doi.org/10.1007/s00384-022-04233-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-022-04233-4

Keywords

Navigation